RecruitingNCT07191951

Shanghai Clinical Cohort - Adrenal Disease


Sponsor

Shanghai Jiao Tong University School of Medicine

Enrollment

600 participants

Start Date

Jul 25, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

As a vital organ responsible for producing life-sustaining hormones, the adrenal gland is associated with a wide range of diseases. These diseases affect multiple systems throughout the body and carry a high rate of mortality and disability. Current diagnosis and treatment face several challenges: significant variability in hormone testing results, inaccurate localization via imaging techniques, unclear molecular characteristics of adrenal tumors, and difficulty in determining prognosis through pathology. Therefore, establishing a clinical research cohort for adrenal diseases is essential. Such a cohort will enable in-depth exploration of disease mechanisms, identification of disease subtypes, optimization of diagnostic criteria, evaluation of treatment efficacy, advancement of personalized medicine, and formulation of prevention and treatment strategies.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria4

  • A signed and dated informed consent form
  • Commitment to abide by the study procedures and cooperate with the implementation of the entire study process
  • Patients diagnosed with adrenal diseases, including aldosteronism, Cushing's syndrome, pheochromocytoma, adrenocortical carcinoma, and congenital adrenal hyperplasia; regardless of whether they have received adrenal surgery, radiotherapy, and/or medication therapy
  • Aged between 18 and 75 years

Exclusion Criteria4

  • Subjects meeting any of the following criteria will be excluded from this study:
  • Refuse to sign the informed consent form
  • Patients without adrenal diseases
  • Have specified diseases or conditions (physical or psychological, identified through physical examination) that warrant exclusion from the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERReceive adrenal surgery, radiotherapy, and/or medication therapy based on diagnosis and subtype classification.

Receive adrenal surgery, radiotherapy, and/or medication therapy based on diagnosis and subtype classification.


Locations(1)

Jiang yiran

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07191951


Related Trials